Korleski, Jack https://orcid.org/0000-0003-3845-7869
Sall, Sophie
Luly, Kathryn M.
Johnson, Maya K.
Johnson, Amanda L. https://orcid.org/0000-0002-3055-945X
Khela, Harmon https://orcid.org/0000-0002-1962-3844
Lal, Bachchu
Taylor, TC
Ashby, Jean Micheal
Alonso, Hector
Li, Alice
Zhou, Weiqiang
Smith-Connor, Karen
Hughes, Russell
Tzeng, Stephany Y.
Laterra, John
Green, Jordan J. https://orcid.org/0000-0003-4176-3808
Lopez-Bertoni, Hernando https://orcid.org/0000-0001-6618-1092
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS120949, R01NS073611, R01NS096754)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA006973, F99CA284254, R37CA246699, R01CA228133)
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (5P50HD103538-05)
John Camp and Mindy Farber '74 Endowed Award
Johns Hopkins University Provost’s Undergraduate Research Award
Life Design Summer Experience Practicum
Summer Academic Research Experience and the Johns Hopkins Initiative for Careers in Science and Medicine
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (P41EB028239)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (S10 OD016374)
Article History
Received: 17 September 2024
Revised: 25 February 2025
Accepted: 27 March 2025
First Online: 30 April 2025
Competing interests
: J.G. and S.T. are managers and co-founders of OncoSwitch. J.G. is a board member, CSO, and co-founder of Cove Therapeutics and a manager, CTO, and co-founder of Dome Therapeutics. Patents related to the technology discussed in the manuscript and any potential conflicts of interest are managed by the Johns Hopkins University Committee on Outside Interests. There are no competing interests from the other authors.